시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 경피 약물전달 시스템 시장 보고서(2025년)
Transdermal Drug Delivery Systems Global Market Report 2025
상품코드 : 1760732
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,192,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,951,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,709,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

경피 약물전달 시스템 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.0%의 성장률(CAGR)로 550억 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 비침습적 치료에 대한 환자 선호도 증가, 만성질환 유병률 증가, 편리한 약물 전달 옵션에 대한 수요 증가, 통증 관리에 대한 적용 확대, 새로운 약물 전달 시스템에 대한 규제 당국의 지원 등의 요인에 의해 이루어질 것으로 예측됩니다. 이 기간의 주요 동향으로는 개인 맞춤형 약물 전달의 혁신, 흡수율 향상을 위한 나노기술의 활용, 스마트 패치 개발, 피부 침투 기술의 발전, 생리활성 화합물의 통합, 만성질환 관리를 위한 웨어러블 디바이스의 발전 등을 들 수 있습니다.

만성질환의 유병률 증가는 향후 경피 약물 전달 시스템 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병, 심장병과 같은 만성질환은 지속적인 관리가 필요하고 일상적인 활동을 제한합니다. 앉아있는 생활습관은 체중 증가, 심혈관계 건강 악화, 대사 불균형 등을 유발하여 만성질환 증가에 일조하고 있습니다. 경피약물전달시스템은 이러한 질환에서 피부를 통해 약물을 지속적으로 제어 방출하여 환자의 복약 순응도를 향상시키고 안정적인 치료 수준을 보장하기 위해 사용됩니다. 예를 들어, 2023년 6월, Institute for Health Metrics and Evaluation은 전 세계 5억 명 이상의 사람들이 당뇨병을 앓고 있으며, 이 숫자는 2050년까지 두 배로 증가하여 13억 명에 이를 것으로 예측했습니다. 이처럼 만성질환의 확산이 경피약물전달시스템 시장의 확대를 견인하고 있습니다.

경피 약물 전달 시스템 시장의 주요 기업들은 약물 흡수와 환자 순응도를 향상시키기 위해 마이크로니들 기술과 같은 기술 발전에 집중하고 있습니다. 마이크로니들은 통증 없이 피부를 통해 약물을 전달할 수 있는 최소침습적 장치로, 기존 주사에 대한 최소침습적 대안을 제공합니다. 예를 들어, 2024년 10월 한국의 대웅제약은 마이크로니들 플랫폼 CLOPAM을 발표했습니다. 이 플랫폼은 약물 전달의 효율성을 크게 향상시키고, 주사에 따른 불편함을 최소화하며, 제어되고 지속적인 약물 방출을 실현합니다. 이 플랫폼의 목표는 경구 또는 주사 치료를 대체할 수 있는 통증이 없고 일관된 치료법을 제공하여 환자의 순응도와 치료 효과를 향상시키는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Transdermal drug delivery systems are methods used to administer medication through the skin, allowing for a controlled, continuous release of the drug into the bloodstream over a period of time. These systems are typically in the form of a patch or similar device applied to the skin, which gradually releases the medication, offering benefits such as avoiding the digestive system and ensuring stable drug levels in the body.

The main types of formulations for transdermal drug delivery systems include drug-in-patch, reservoir, matrix, and microreservoir types. The drug-in-patch formulation is especially common in the consumer health market due to its convenience, making it ideal for treatments such as nicotine replacement and hormone therapy. Key technologies used in transdermal drug delivery include iontophoresis and microporation. These systems are applied in various fields, including pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and are used in settings such as hospitals, home healthcare, pharmaceutical companies, and research institutions.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including the transdermal drug delivery systems industry global market size, regional shares, competitors with the transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends, and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $37.30 billion in 2024 to $40.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as an increased demand for non-invasive drug delivery, better patient adherence to treatments, enhanced bioavailability, a rise in chronic disease prevalence, and a growing preference for self-administration.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $55.00 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period is driven by factors including a greater patient preference for non-invasive treatments, the rising prevalence of chronic diseases, an increasing demand for convenient drug delivery options, expanded uses in pain management, and regulatory support for new drug delivery systems. Key trends during this period include innovations in personalized drug delivery, the use of nanotechnology for improved absorption, the development of smart patches, advancements in skin penetration techniques, the incorporation of bioactive compounds, and breakthroughs in wearable devices for managing chronic conditions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the future. Chronic diseases, such as diabetes and heart disease, require ongoing management and limit daily activities. Factors such as sedentary lifestyles, which lead to weight gain, poor cardiovascular health, and metabolic imbalances, contribute to the rise in chronic conditions. Transdermal drug delivery systems are used in these diseases to provide a continuous, controlled release of medication through the skin, improving patient adherence and ensuring stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion people worldwide were living with diabetes, with this number expected to double, reaching 1.3 billion by 2050. Thus, the growing prevalence of chronic diseases is driving the market expansion for transdermal drug delivery systems.

Key players in the transdermal drug delivery systems market are concentrating on technological advancements such as microneedle technology to improve drug absorption and patient compliance. Microneedles are minimally invasive devices that deliver drugs through the skin painlessly, offering a less invasive alternative to traditional injections. For example, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This platform significantly enhances drug delivery efficiency, minimizes the discomfort associated with injections, and provides controlled, sustained medication release. The goal is to offer a painless and consistent alternative to oral or injectable treatments, thereby improving patient compliance and treatment effectiveness.

In August 2022, LTS Lohmann Therapie-Systeme AG, a pharmaceutical company based in Germany, acquired Tapemark Inc. for an undisclosed amount. This acquisition strengthens LTS's drug delivery capabilities, expanding its expertise in production and bolstering its position in the field of transdermal and advanced drug delivery solutions. Tapemark Inc., based in the US, specializes in the manufacturing of transdermal drug delivery systems.

Major players in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, 3M Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan NV, UCB S.A., Skyepharma, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies, Inc., Grunenthal GmbH, 4P Therapeutics LLC, and Actavis Inc.

North America was the largest region in the transdermal drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transdermal drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the defined geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Transdermal Drug Delivery Systems Market Characteristics

3. Transdermal Drug Delivery Systems Market Trends And Strategies

4. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transdermal Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

6. Transdermal Drug Delivery Systems Market Segmentation

7. Transdermal Drug Delivery Systems Market Regional And Country Analysis

8. Asia-Pacific Transdermal Drug Delivery Systems Market

9. China Transdermal Drug Delivery Systems Market

10. India Transdermal Drug Delivery Systems Market

11. Japan Transdermal Drug Delivery Systems Market

12. Australia Transdermal Drug Delivery Systems Market

13. Indonesia Transdermal Drug Delivery Systems Market

14. South Korea Transdermal Drug Delivery Systems Market

15. Western Europe Transdermal Drug Delivery Systems Market

16. UK Transdermal Drug Delivery Systems Market

17. Germany Transdermal Drug Delivery Systems Market

18. France Transdermal Drug Delivery Systems Market

19. Italy Transdermal Drug Delivery Systems Market

20. Spain Transdermal Drug Delivery Systems Market

21. Eastern Europe Transdermal Drug Delivery Systems Market

22. Russia Transdermal Drug Delivery Systems Market

23. North America Transdermal Drug Delivery Systems Market

24. USA Transdermal Drug Delivery Systems Market

25. Canada Transdermal Drug Delivery Systems Market

26. South America Transdermal Drug Delivery Systems Market

27. Brazil Transdermal Drug Delivery Systems Market

28. Middle East Transdermal Drug Delivery Systems Market

29. Africa Transdermal Drug Delivery Systems Market

30. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

31. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

32. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

34. Recent Developments In The Transdermal Drug Delivery Systems Market

35. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기